Overexpression of EZH2 was associated with tumor malignancy and a poor prognosis in human cancers including nasopharyngeal esophageal, breast, gastric, hepatic, pancreatic, ovarian, and bladder cancers [17–19]. This evidence concerns the gene EZH2 and cancer.